CARIS LIFE SCIENCES INC (CAI) Fundamental Analysis & Valuation

NASDAQ:CAI • US1421521071

18.59 USD
-0.63 (-3.28%)
At close: Mar 6, 2026
18.59 USD
0 (0%)
After Hours: 3/6/2026, 8:04:09 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

4

Taking everything into account, CAI scores 4 out of 10 in our fundamental rating. CAI was compared to 519 industry peers in the Biotechnology industry. CAI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CAI is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. CAI Profitability Analysis

1.1 Basic Checks

  • CAI had positive earnings in the past year.
CAI Yearly Net Income VS EBIT VS OCF VS FCFCAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -101.38%, CAI is doing worse than 75.58% of the companies in the same industry.
  • The Return On Equity of CAI (-208.66%) is worse than 68.85% of its industry peers.
Industry RankSector Rank
ROA -101.38%
ROE -208.66%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CAI Yearly ROA, ROE, ROICCAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

  • Looking at the Gross Margin, with a value of 53.54%, CAI is in the better half of the industry, outperforming 76.35% of the companies in the same industry.
  • CAI does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CAI Yearly Profit, Operating, Gross MarginsCAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CAI Health Analysis

2.1 Basic Checks

  • CAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CAI remains at a similar level compared to 1 year ago.
  • Compared to 5 years ago, CAI has more shares outstanding
  • CAI has a worse debt/assets ratio than last year.
CAI Yearly Shares OutstandingCAI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2023 2024 50M 100M 150M 200M 250M
CAI Yearly Total Debt VS Total AssetsCAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 3.57 indicates that CAI is not in any danger for bankruptcy at the moment.
  • With a decent Altman-Z score value of 3.57, CAI is doing good in the industry, outperforming 68.85% of the companies in the same industry.
  • A Debt/Equity ratio of 0.79 indicates that CAI is somewhat dependend on debt financing.
  • CAI has a Debt to Equity ratio of 0.79. This is in the lower half of the industry: CAI underperforms 72.12% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Altman-Z 3.57
ROIC/WACCN/A
WACC9.06%
CAI Yearly LT Debt VS Equity VS FCFCAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 9.93 indicates that CAI has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 9.93, CAI belongs to the top of the industry, outperforming 80.38% of the companies in the same industry.
  • A Quick Ratio of 9.36 indicates that CAI has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 9.36, CAI is doing good in the industry, outperforming 79.23% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 9.93
Quick Ratio 9.36
CAI Yearly Current Assets VS Current LiabilitesCAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CAI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 191.16% over the past year.
  • Measured over the past years, CAI shows a quite strong growth in Earnings Per Share. The EPS has been growing by 12.17% on average per year.
  • Looking at the last year, CAI shows a decrease in Revenue. The Revenue has decreased by -1.64% in the last year.
  • Measured over the past years, CAI shows a small growth in Revenue. The Revenue has been growing by 4.83% on average per year.
EPS 1Y (TTM)191.16%
EPS 3Y14.52%
EPS 5Y12.17%
EPS Q2Q%N/A
Revenue 1Y (TTM)-1.64%
Revenue growth 3Y-2.37%
Revenue growth 5Y4.83%
Sales Q2Q%-28.96%

3.2 Future

  • Based on estimates for the next years, CAI will show a very negative growth in Earnings Per Share. The EPS will decrease by -19.81% on average per year.
  • Based on estimates for the next years, CAI will show a quite strong growth in Revenue. The Revenue will grow by 17.18% on average per year.
EPS Next Y83.59%
EPS Next 2Y44.25%
EPS Next 3Y19.27%
EPS Next 5Y-19.81%
Revenue Next Year5.75%
Revenue Next 2Y8.24%
Revenue Next 3Y5.04%
Revenue Next 5Y17.18%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CAI Yearly Revenue VS EstimatesCAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B
CAI Yearly EPS VS EstimatesCAI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 6 8

More info and screens

Find the best growth stocksShow best growing peers

6

4. CAI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 4.34, which indicates a rather cheap valuation of CAI.
  • 99.23% of the companies in the same industry are more expensive than CAI, based on the Price/Earnings ratio.
  • CAI's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.29.
  • A Price/Forward Earnings ratio of 2.09 indicates a rather cheap valuation of CAI.
  • Based on the Price/Forward Earnings ratio, CAI is valued cheaper than 99.23% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 24.57. CAI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.34
Fwd PE 2.09
CAI Price Earnings VS Forward Price EarningsCAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CAI Per share dataCAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CAI's earnings are expected to grow with 19.27% in the coming years.
PEG (NY)0.05
PEG (5Y)0.36
EPS Next 2Y44.25%
EPS Next 3Y19.27%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CAI Dividend Analysis

5.1 Amount

  • CAI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAI Fundamentals: All Metrics, Ratios and Statistics

CARIS LIFE SCIENCES INC

NASDAQ:CAI (3/6/2026, 8:04:09 PM)

After market: 18.59 0 (0%)

18.59

-0.63 (-3.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners50.55%
Inst Owner Change21.03%
Ins Owners48.41%
Ins Owner Change1.33%
Market Cap5.25B
Revenue(TTM)294.00M
Net Income(TTM)-998.17M
Analysts85.71
Price Target37.43 (101.34%)
Short Float %5.02%
Short Ratio2.54
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1853.44%
Min EPS beat(2)-3845.54%
Max EPS beat(2)138.66%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)28.77%
Min Revenue beat(2)26.17%
Max Revenue beat(2)31.38%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.14%
PT rev (3m)-6.79%
EPS NQ rev (1m)4308%
EPS NQ rev (3m)174.63%
EPS NY rev (1m)4.23%
EPS NY rev (3m)14.45%
Revenue NQ rev (1m)11.58%
Revenue NQ rev (3m)16.76%
Revenue NY rev (1m)3.62%
Revenue NY rev (3m)11.68%
Valuation
Industry RankSector Rank
PE 4.34
Fwd PE 2.09
P/S 5.64
P/FCF N/A
P/OCF N/A
P/B 10.98
P/tB 11.44
EV/EBITDA N/A
EPS(TTM)4.28
EY23.02%
EPS(NY)8.91
Fwd EY47.91%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.3
BVpS1.69
TBVpS1.62
PEG (NY)0.05
PEG (5Y)0.36
Graham Number12.77
Profitability
Industry RankSector Rank
ROA -101.38%
ROE -208.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.54%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.79
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.93
Quick Ratio 9.36
Altman-Z 3.57
F-ScoreN/A
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)191.16%
EPS 3Y14.52%
EPS 5Y12.17%
EPS Q2Q%N/A
EPS Next Y83.59%
EPS Next 2Y44.25%
EPS Next 3Y19.27%
EPS Next 5Y-19.81%
Revenue 1Y (TTM)-1.64%
Revenue growth 3Y-2.37%
Revenue growth 5Y4.83%
Sales Q2Q%-28.96%
Revenue Next Year5.75%
Revenue Next 2Y8.24%
Revenue Next 3Y5.04%
Revenue Next 5Y17.18%
EBIT growth 1Y19.54%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year128.02%
EBIT Next 3Y45.1%
EBIT Next 5Y31.2%
FCF growth 1Y15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y11.19%
OCF growth 3YN/A
OCF growth 5YN/A

CARIS LIFE SCIENCES INC / CAI FAQ

What is the fundamental rating for CAI stock?

ChartMill assigns a fundamental rating of 4 / 10 to CAI.


Can you provide the valuation status for CARIS LIFE SCIENCES INC?

ChartMill assigns a valuation rating of 6 / 10 to CARIS LIFE SCIENCES INC (CAI). This can be considered as Fairly Valued.


Can you provide the profitability details for CARIS LIFE SCIENCES INC?

CARIS LIFE SCIENCES INC (CAI) has a profitability rating of 1 / 10.


Can you provide the PE and PB ratios for CAI stock?

The Price/Earnings (PE) ratio for CARIS LIFE SCIENCES INC (CAI) is 4.34 and the Price/Book (PB) ratio is 10.98.


What is the expected EPS growth for CARIS LIFE SCIENCES INC (CAI) stock?

The Earnings per Share (EPS) of CARIS LIFE SCIENCES INC (CAI) is expected to grow by 83.59% in the next year.